Patent US2930400A successfully refreshed from Google Patents.
Patent US4729139A successfully refreshed from Google Patents.
US4729139A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
Assignee: SEDATELEC A CORP OF FRANCE Ste
•
Filing: 1985-11-05
•
Granted: 1988-03-08
•
Expires: 2005-11-05
Abstract
Abstract A process for selectively incorporating biocompatible polymers in the interstices of implantable biological tissue while leaving the outer surface of the tissue substantially free of bonded polymer. The process involves covalently binding a monomer to the tissue, contacting the tissue with a free-radical initiator, then contacting the tissue with a solution containing a second monomer and a free-radical scavenger, thereby promoting selective polymerization of the second monomer with the portion of covalently-bound first monomer which is located in the interstices of the tissue.
Inventors
- 👤 Aws S. Nashef
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:41
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3683; A61L27/3687; A61L2400/00; A61L2400/02; Y; Y10; Y10S; Y10S623/00; Y10S623/915; Y10S623/918
Claims Analysis
Total Claims: 31
Claim 1
Independent Claim
116 words
A process for treating animal biological tissue prior to implantation in an animal to reduce calcification of said tissue after implantation comprising the steps of: (a) fixing said tissue under tissue-fixing conditions; (b) contacting said fixed tissue with a first solution of one or more monomers under conditions sufficient to covalently bond said monomer(s) to the tissue; (c) contacting said tissue with a polymerization initiator; and (d) contacting said tissue with a second solution containing one or more monomers or oligomers under polymerization conditions in presence of a polymerization-inhibiting free-radical scavenger, such that the second monomer(s) or oligomer(s) polymerize with said covalentyl-bound first monomer(s) and the resulting polymer is concentrated in the interstices of the tissue.
Claim 2
Dependent Claim
116 words
A process for treating animal biological tissue prior to implantation in an animal to reduce calcification of said tissue after implantation comprising the steps of: (a) fixing said tissue under tissue-fixing conditions; (b) contacting said fixed tissue with a first solution of one or more monomers under conditions sufficient to covalently bond said monomer(s) to the tissue; (c) contacting said tissue with a polymerization initiator; and (d) contacting said tissue with a second solution containing one or more monomers or oligomers under polymerization conditions in presence of a polymerization-inhibiting free-radical scavenger, such that the second monomer(s) or oligomer(s) polymerize with said covalentyl-bound first monomer(s) and the resulting polymer is concentrated in the interstices of the tissue.
Claim 3
Dependent Claim
26 words
The process of claim 1 wherein said free-radical scavenger is selected from the group consisting of ferrous ammonium sulfate, ascorbic acid, potassium ferricyanide, or cupric nitrate.
Claim 4
Dependent Claim
26 words
The process of claim 1 wherein said free-radical scavenger is ferrous ammonium sulfate and said polymerization initiator is an aqueous solution containing ammonium persulfate and N,N,N',N'-tetramethy-lenediamine.
Claim 5
Dependent Claim
53 words
The process of claim 1 wherein said free-radical scavenger is present in the second monomer solution in an amount effective in minimizing homopolymerization of the second monomers in solution and selectively quenching free radicals on the outer surfaces of the tissue, without substantially quenching free radicals in the interior portions of the tissue,
Claim 6
Dependent Claim
34 words
The process of claim 4 wherein said free-radical scavenger is present in the second monomer solution in amounts of from about 0.15 to about 0.4 weight percent of the total weight of said solution.
Claim 7
Dependent Claim
34 words
The process of claim 5 wherein said free-radical scavenger is present in the second monomer solution in amounts of from about 0.2 to about 0.3 weight percent of the total weight of said solution.
Claim 8
Dependent Claim
19 words
The process of claim 6 wherein said second monomer solution contains about 0.25 weight percent of said free-radical scavenger.
Claim 9
Dependent Claim
23 words
The process of claim 1 further comprising the step of removing the non-covalently bound monomer from said tissue between steps (b) and (c).
Claim 10
Dependent Claim
23 words
The process of claim 1 wherein said first monomer solution contains acrylic acid, methacrylic acid and/or derivatives thereof, including amides and esters thereof.
Claim 11
Dependent Claim
28 words
The process of claim 1 wherein said second monomer solution comprises acrylamide, acrylic acid, esters of acrylic acid, methacrylic acid, methacrylamide, esters of methacrylic acid or mixtures thereof.
Claim 12
Dependent Claim
38 words
The process of claim 1 wherein said first monomer is acrylic acid or methacrylic acid, and said second monomer solution comprises acrylamide, acrylic acid, esters of acrylic acid, methacrylic acid, methacrylamide, esters of methacrylic acid or mixtures thereof.
Claim 13
Dependent Claim
23 words
The process of claim 1 wherein the first monomer covalently bound to said tissue is acrylic acid, and the second monomer is acrylamide.
Claim 14
Dependent Claim
14 words
The process of claim 1 wherein said second solution additionally comprises a cross-linking agent.
Claim 15
Dependent Claim
11 words
The process of claim 13 wherein said cross-linking agent is bisacrylamide.
Claim 16
Dependent Claim
16 words
The process of claim 14 wherein said second solution contains about 0.25 weight percent of bisacrylamide.
Claim 17
Dependent Claim
32 words
The process of claim 1 wherein monomers are suspended in the second monomer solution in amounts of from about 0.1 to about 10.0 weight percent of the total weight of the solution.
Claim 18
Dependent Claim
32 words
The process of claim 16 wherein monomers are suspended in the second monomer solution in amounts of from about 0.5 to about 6.0 weight percent of the total weight of the solution.
Claim 19
Dependent Claim
32 words
The process of claim 17 wherein monomers are suspended in the second monomer solution in amounts of from about 0.5 to about 2.0 weight percent of the total weight of the solution.
Claim 20
Dependent Claim
35 words
The process of claim 1, wherein said biological tissue is a tendon, ligament, heart valve, dura mater, fascia lata, amnion, or pericardium taken from a bovine, porcine, horse, sheep, kangaroo, rabbit, or human cadaver source.
Claim 21
Dependent Claim
13 words
The process of claim 1 wherein said biological tissue is fixed with glutaraldehyde.
Claim 22
Dependent Claim
37 words
The process of claim 1 further comprising covalently binding a spacer to said fixed tissue between steps (a) and (b) so that the monomer(s) in said first solution is/are covalently bound to said tissue through the spacer.
Claim 23
Dependent Claim
12 words
The process of claim 21 wherein said spacer is a diamine compound.
Claim 24
Dependent Claim
34 words
The process of claim 22 wherein said diamine compound has the formula R--(NH 2 ) 2 , wherein R is an aliphatic group having a straight, branched or cyclic chain, or an aromatic group.
Claim 25
Dependent Claim
11 words
The process of claim 23 wherein said diamine compound is ethylenediamine.
Claim 26
Dependent Claim
21 words
The process of claim 22 wherein said diamine is covalently bound to said fixed tissue in the presence of a carbodiimide.
Claim 27
Dependent Claim
109 words
A process for treating animal biological tissue prior to implantation in an animal to reduce calcification of said tissue after implantation comprising steps of (a) fixing said tissue under tissue-fixing conditions; (b) contacting said tissue with a first solution containing one or more monomers capable of further polymerization under conditions sufficient to impregnate said monomer(s) in said tissue; and (c) contacting said tissue with a second solution containing one or more monomers or oligomers under polymerization conditions in the presence of a polymerization-inhibiting free-radical scavenger, such that the second monomer(s) or oligomer(s) polymerize with said first monomer(s) and the resulting polymer is concentrated in the interstices of the tissue.
Claim 28
Dependent Claim
109 words
A process for treating animal biological tissue prior to implantation in an animal to reduce calcification of said tissue after implantation comprising steps of (a) fixing said tissue under tissue-fixing conditions; (b) contacting said tissue with a first solution containing one or more monomers capable of further polymerization under conditions sufficient to impregnate said monomer(s) in said tissue; and (c) contacting said tissue with a second solution containing one or more monomers or oligomers under polymerization conditions in the presence of a polymerization-inhibiting free-radical scavenger, such that the second monomer(s) or oligomer(s) polymerize with said first monomer(s) and the resulting polymer is concentrated in the interstices of the tissue.
Claim 29
Dependent Claim
24 words
The process of claim 26 wherein said first monomer solution comprises acrylic acid, methacrylic acid, and/or derivatives thereof, including amide and ester derivatives thereof.
Claim 30
Dependent Claim
28 words
The process of claim 26 wherein said second monomer solution comprises acrylamide, acrylic acid, esters of acrylic acid, methacrylic acid, methacrylamide, esters of methacrylic acid or mixtures thereof.
Claim 31
Dependent Claim
30 words
Biological tissue having a reduced tendency toward calcification after implantation in an animal, said tissue having a polymer incorporated therein according to the process of claim 1, 21, or 26.
References Cited (Backward Citations)
US4120649A
Cited
US4182750A
Cited
US4066583A
Cited
US4377010A
Cited
US4383832A
Cited
US4314800A
Cited
US4378224A
Cited
US4369036A
Cited
US4323358A
Cited
US4350806A
Cited
US4481009A
Cited
US4402697A
Cited
US4511478A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-03-08 | 1991-09-07 | 1992-03-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-03-08 | 1995-09-07 | 1996-03-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-03-08 | 1999-09-07 | 2000-03-08 | $7700.00 | Window Closed / Lapsed |